Chinese investment firm sells New Zealand investment to Nestle

Updated: July 1, 2022 Source: chinadaily.com.cn
fontLarger fontSmaller

The logo of Nestle Health Science. [Photo/nestlehealthscience.com]

Chinese alternative assets management firm CDH Investments announced on June 29 that it and the founding shareholders of The Better Health Company (TBHC) had agreed to sell the New Zealand-based natural health products company to Nestle Health Science.

In 2016, Beijing-based CDH invested in TBHC and became its controlling shareholder. TBHC owns the GO Healthy brand, a major supplement brand in New Zealand's advice channel; the Egmont Honey brand, one of the largest producers and marketers of Manuka honey; and New Zealand Health Manufacturing, one of the leading supplement manufacturing businesses in Oceania.

The TBHC deal was the second exit deal of CDH this year, coming one month after it sold an investment in Vietnam's restaurant chain Golden Gate.

CDH is one of the proactive Chinese investment firms in investing in cross border assets including Smithfield, the US pork producer and food-processing company.

Editor: Duan Jing